Sort
48,018 grants matching “immunotherapy”
Validating the hybrid epithelial/mesenchymal state as a biomarker of treatment response and outcomes in head and neck cancer
$702,871Sidharth Venkata Puram · Washington University · U01 · FY2025 · DE
Topical proprietary biologic to treat oral mucositis
$702,863Christian Young · Allander Biotechnologies, Inc. · R44 · FY2018 · DE
Determining the role of neutrophils in anti-tumor immunity and immune-related adverse events in the context of T cell-based therapies
$702,748Taha Merghoub · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Novel therapeutic approaches for enhancing anti-tumor immunity in SCLC
$702,580John V. Heymach · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · CA
Targeting Tumor-Associated Macrophages to Treat Lymphoma
$702,495Wendong Huang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Targeting HIV-specific CAR T cells to the gut for the durable remission of HIV
$702,446Pamela J Skinner · University Of Minnesota · R01 · FY2025 · DK
Leveraging PMN immune response to overcome ADT resistance in bone metastatic prostate cancer
$702,262Grinu Mathew · University Of Nebraska Medical Center · R01 · FY2025 · CA
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns
$702,125Lyle L Moldawer · University Of Florida · R01 · FY2017 · HD
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
$702,059Benjamin G. Neel · New York University School Of Medicine · R01 · FY2025 · CA
Evaluation of an implantable microdevice for rapid cancer drug screening directly in T cell lymphoma patients
$702,007Cecilia Larocca · Brigham And Women'S Hospital · R37 · FY2023 · CA
Career Development in Pediatric and Medical Oncology
$701,719Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2017 · CA
Precision imaging of the spatial regulators of the hybrid epithelial/mesenchymal state in head and neck cancer
$701,699Shannon L Stott · Massachusetts General Hospital · R01 · FY2024 · DE
Elucidating resistance mechanisms and enhancing response to immune checkpoint blockade in central nervous system metastases from breast cancer
$701,661Priscilla Kaliopi Brastianos · Massachusetts General Hospital · R01 · FY2025 · CA
Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC)
$701,658Antony Rosen · Johns Hopkins University · P30 · FY2025 · AR
Development of multinuclear MRI for image guided therapy of glioma patients
$701,639Ovidiu C Andronesi · Massachusetts General Hospital · R01 · FY2025 · CA
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
$701,440Robert J Gray · Dana-Farber Cancer Inst · U01 · FY2018 · CA
Immune reconstitution following autologous and allogeneic stem cell transplant
$701,433Frances Hakim · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
NCI X-ray free electron laser (XFEL) initiative
$701,422Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Elucidating resistance mechanisms and enhancing response to immune checkpoint blockade in central nervous system metastases from breast cancer
$701,408Priscilla Kaliopi Brastianos · Massachusetts General Hospital · R01 · FY2024 · CA
Research Project 1 - Targeting the MAPK and PI3K pathways in melanoma PDX
$700,949Meenhard Herlyn · Wistar Institute · U54 · FY2017 · CA
Immunologic Basis of Cow's Milk-Induced Hypersensitivities
$700,728Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2009 · AI
The COVID-19 and Cancer Consortium (CCC19) Registry
$700,645Jeremy Lyle Warner · Rhode Island Hospital · U01 · FY2025 · CA
A prospective evaluation of the gut microbiome as a mediator of lymphoma treatment outcome and systemic immunity
$700,561Catherine Sibyl Diefenbach · New York University School Of Medicine · R01 · FY2025 · CA
Membrane-based vaccine with checkpoint blockade for triple negative breast cancer
$700,539Kamal V. Kannan · Metaclipse Therapeutics Corporation · R44 · FY2017 · CA
The Epigenetic Enzyme CARM1 as a Negative Regulator of Dendritic cells and CD8 T cells in Melanoma
$700,514Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2024 · CA